SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is trending following recent analyst downgrades, which many in the community interpret as a strategic effort by institutions to accumulate shares at lower prices. Despite ongoing discussions about profitability and past governance, there is strong community focus on the company's significant revenue growth in AI infrastructure and its recent expansion into new sectors like AI-powered retail solutions. The market awaits upcoming earnings for further clarity on its trajectory and the impact of these developments.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Advanced Micro Devices is trending after a major analyst upgrade cited surging hyperscaler demand and strong AI accelerator bookings, reporting that its server CPUs are nearly sold out for an extended period. The community is buzzing with optimism, discussing a potential short squeeze and AMD's strengthening position in the competitive AI and data center markets.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings (RCAT) is trending following strong preliminary Q4 2025 revenue results, generating significant community buzz around its potential for major defense contracts. Investors are highly optimistic about RCAT's Black Widow drones, speculating on their recent use in military operations and eagerly anticipating awards from the upcoming Drone Dominance Program, with many also noting high short interest and perceived undervaluation.

Ambitions Enterprise Management Co. LLC operates as a travel agency. It provides event planning and management services. The firm also offers transportation, accommodations, meals, and guided tours or activities under convenient packages. The company was founded on October 26, 2023 and is headquartered in Dubai, United Arab Emirates.

Ambitions Enterprise Management Co LLC - Ordinary Shares - Class A

Ambitions Enterprise Management Co LLC

AHMA is trending sharply upward on unusually high volume, sparking intense community discussion about its low float and potential for a significant short squeeze. Traders are actively drawing parallels to other recent high-flying IPOs, highlighting the price action despite a lack of explicit company news.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan Chase is trending after reporting financial results that surpassed expectations, kicking off the bank earnings season. The community is actively discussing the company's strong performance and CEO Jamie Dimon's resilient economic outlook, though some traders are weighing a significant credit reserve build related to the Apple Card transition and potential impacts from proposed credit card interest rate caps.

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.

BriaCell Therapeutics Corp - Ordinary Shares - New

BriaCell Therapeutics Corp

BriaCell Therapeutics is trending after reporting the sustained complete resolution of lung metastasis in a single patient with advanced breast cancer treated with its Bria-OTS personalized immunotherapy. This promising clinical update has ignited strong bullish sentiment and speculation about significant price movement, though many investors remain cautious due to the stock's history of offerings and reverse splits. The company continues to advance its Phase 3 trials, with further data expected at upcoming medical conferences, maintaining a mixed outlook among the community.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is trending as investors keenly anticipate potential breakthroughs for its GaN and SiC power solutions, which are critical for energy-efficient next-generation AI data centers and strategic alignment with key industry players like NVIDIA. The community is highly focused on the stock's significant short interest, sparking intense discussion about a potential squeeze and a substantial breakout driven by its foundational technology in the evolving AI ecosystem.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending following a softer-than-expected core CPI report, signaling inflation may be cooling faster than anticipated. This dovish surprise is fueling widespread market optimism and driving expectations for a strong rally, despite some community members expressing skepticism about the reported economic data. Discussions revolve around whether this signals continued upside or if underlying economic concerns will eventually lead to a shift.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending due to widespread community belief in an ongoing short squeeze, fueled by reports of tightening physical silver supply and its growing designation as a critical mineral for industrial demand from sectors like AI and EVs. While many anticipate substantial price appreciation, a significant bearish contingent warns of an impending sharp pullback, pointing to potential rebalancing activities and historical market behavior.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as investors keenly await significant news regarding its Optical Interposer technology, vital for high-speed, energy-efficient data transfer in AI and hyperscale data centers. The community is actively discussing potential large purchase orders or partnerships, especially following key industry developments from Nvidia and Marvell, positioning POET within the burgeoning photonics sector. Many anticipate strong catalysts, believing the company is on the cusp of a substantial re-rating as it moves towards mass production and wider adoption.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) CFO Sells $502,680.00 in Stock

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Get Free Report) CFO Mark Ragosa sold 12,000 shares of the stock in a transaction dated Thursday, January 8th. The shares were sold at an...

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock Price Down 6.2% - Here's What Happened

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock Price Down 6.2% - Time to Sell...

Rice Hall James & Associates LLC Reduces Stock Position in Kiniksa Pharmaceuticals International, plc $KNSA

Rice Hall James & Associates LLC lowered its position in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Free Report) by 9.5% during the third quarter, according to the company in its most...

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Average Rating of "Moderate Buy" by Analysts

Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Get Free Report) have been assigned an average rating of "Moderate Buy" from the eight research firms that are currently covering...

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) COO Sells $500,714.88 in Stock

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Get Free Report) COO Eben Tessari sold 12,048 shares of the stock in a transaction that occurred on Monday, December 15th. The stock was sold...

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Director Barry Quart Sells 20,129 Shares

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Get Free Report) Director Barry Quart sold 20,129 shares of the business's stock in a transaction that occurred on Monday, December 15th. The...

Braidwell LP Sells 860,329 Shares of Kiniksa Pharmaceuticals International, plc $KNSA

Braidwell LP lessened its holdings in shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Free Report) by 43.8% during the second quarter, according to the company in its most recent...

Insider Selling: Kiniksa Pharmaceuticals International (NASDAQ:KNSA) CFO Sells 42,841 Shares of Stock

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Get Free Report) CFO Mark Ragosa sold 42,841 shares of the stock in a transaction that occurred on Monday, December 8th. The shares were sold...

Kiniksa Pharmaceuticals International, plc $KNSA Shares Bought by Walleye Capital LLC

Walleye Capital LLC increased its holdings in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Free Report) by 39.1% in the 2nd quarter, according to its most recent 13F filing with the SEC...

Wedbush Reiterates Outperform Rating for Kiniksa Pharmaceuticals International (NASDAQ:KNSA)

Wedbush reissued an "outperform" rating and issued a $48.00 price target on shares of Kiniksa Pharmaceuticals International in a report on Tuesday...

Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.

Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

KNSA
Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest KNSA News

KNSAKiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A